Table 1 of Dratviman-Storobinsky, Mol Vis 2009; 15:2326-2338. Table 1 of Dratviman-Storobinsky, Mol Vis 2009; 15:2326-2338.
Table 1. Mice used in the study.
| Procedure | Model-untreated (n=56) |
Bevacizumab-treated (n=63) | |||
|---|---|---|---|---|---|
| SC (n=22) | IV (n=20) | IC (n=21) | Total (n=63) | ||
| In vivo digital photographs | 32 | 20 | 18 | 19 | 57 |
| India ink (flat cornea) | 2 | 2 | 2 | 2 | 6 |
| Fluorescein angiography | 4 | - | - | - | - |
| Histology (H&E) | 8 | 8 | 8 | 8 | 24 |
| Corneal flat mounts | 4 | - | - | - | - |
| Antibody staining | - | - | 4 | - | 4 |
| Real-time PCR | 10 | 12 | 12 | 19 | 57 |